Therapeutic strategies in Huntington’s disease

Author： Alberch Jordi Canals Josep M Pérez-Navarro Esther

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.4, 2003-04, pp. : 449-465

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel therapeutic targets for Huntington’s disease

By Hannan Anthony J

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 639-650

Informa Healthcare

Access to resources Recommend Favorite

Emerging chemotherapeutic strategies for Huntington’s disease

By Ryu Hoon Ferrante Robert J

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 345-363

Informa Healthcare

Access to resources Recommend Favorite

Neuroprotection in Huntington;s Disease

Letters in Drug Design & Discovery, Vol. 2, Iss. 2, 2005-03 ,pp. : 143-147

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Oxidative Stress in Huntington’s Disease: Are Antioxidants Good Therapeutic Candidates?

Current Drug Targets, Vol. 15, Iss. 4, 2014-04 ,pp. : 454-468

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Strategies for Huntington's Disease: From the Bench to the Clinic

Current Psychopharmacology, Vol. 1, Iss. 2, 2012-05 ,pp. : 137-154

Bentham Science Publishers

Access to resources Recommend Favorite